VIGL Pangali Forward P/E Vigil Neuroscience Inc.
Vigil Neuroscience focuses on developing microglia-modulating drugs for brain degeneration and the therapy of rare pathologies. The company's forward P/E clearly demonstrates the value of expected earnings, while 0.00 reflects the latest value of the metric. The diversification of immunological approaches expands its presence in neuromedicine, and its independence from macroeconomic factors transforms the asset into a resilient defensive tool.
Rincian metrik keuangan lan pasar Vigil Neuro (VIGL)
- kuotasi lan prakiraan analis:
- data kapitalisasi pasar:
- informasi kapitalisasi buku:
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Vigil Neuroscience|VIGL - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Vigil Neuroscience|VIGL - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Vigil Neuroscience Inc.|VIGL - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Vigil Neuroscience|Likuiditas cepet vigilneuro.com
- statistik bathi lan rasio pasar:
VIGL - Bathi pungkasan|Bathi sing dikarepake Vigil Neuroscience|VIGL - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Vigil Neuroscience|VIGL - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Vigil Neuroscience Inc.|VIGL - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Vigil Neuroscience|VIGL - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan vigilneuro.com|VIGL - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Vigil Neuroscience
- data pendapatan lan penerimaan dodolan:
Ringkesan analitik perusahaan:Vigil Neuroscience, Inc.
The forward P/E ratio dynamics for Vigil Neuroscience (VIGL) reflect market expectations regarding the implementation of robotic screening and the automation of TREM2 receptor data analysis. This indicator correlates the current share price with the consensus forecast for future earnings per share, allowing investors to assess the level of optimism priced in and the risk of a correction should the pace of commercialization deviate from expectations.
Pesaing Vigil Neuroscience (VIGL)
Pangali Forward P/E BIIB|Kapitalisasi marang proyeksi bathi Neurocrine|Pangali Forward P/E RGC (Regencell)|Pangali forward rega marang bathi Axsome Corp|ACADIA Pharmaceuticals - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi xenon-pharma.com XENE|Viking Therapeutics, Inc. (VKTX) - Rega marang bathi mangsa ngarep|SUPN (Supernus Pharmaceuticals, Inc.) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi CPRX|DNLI: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Harmony Biosciences (HRMY)|biohavenpharma.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E AMLX (Amylyx Pharmaceuticals, Inc.)|Trevi Therapeutics Inc (TRVI) - Rasio prakiraan rega marang bathi|PRAX: Prakiraan rega marang bathi|AVXL - Pangali Forward P/E|CeriBell, Inc. (CBLL) - Rega marang bathi mangsa ngarep|Prothena - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Alector Inc.|Rasio prakiraan rega marang bathi Annexon Biosciences ANNX|Rega marang bathi mangsa ngarep Omeros Corporation (OMER)|Kapitalisasi marang proyeksi bathi Neurogene Therapeutics|Pangali Forward P/E ACIU (AC Immune)|VYGR - Prakiraan rega marang bathi|Neumora Therapeutics, Inc. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Scilex Holding SCLX|TVGN: Pangali Forward P/E|Rasio prakiraan rega marang bathi Alpha Cognition Inc. (ACOG)|Rega marang bathi mangsa ngarep Cognition Therapeutics|Rasio rega marang bathi mangsa ngarep IKT (inhibikase.com)|Pangali Forward P/E SAVA|Prakiraan rega marang bathi assertiotx.com ASRT|Pangali Forward P/E COYA (Coya Therapeutics)|VistaGen Therapeutics, Inc. (VTGN) - Rasio prakiraan rega marang bathi|OVID: Prakiraan rega marang bathi|ABOS: Rega marang bathi mangsa ngarep|CRVO: Pangali Forward P/E|ATHE - Kapitalisasi marang proyeksi bathi|CLNN (Clene Inc) - Pangali Forward P/E|PEPG - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep Jupiter Neurosciences Inc (JUNS)|Rega marang bathi mangsa ngarep RLMD (relmada.com)|Rega marang bathi mangsa ngarep Annovis Bio ANVS|GRCE: Rasio rega marang bathi mangsa ngarep|Firefly Neuroscience Inc - Pangali Forward P/E|Rasio prakiraan rega marang bathi Klotho Neurosciences Inc|NRSN (neurosense-tx.com) - Prakiraan rega marang bathi|revivapharma.com (RVPH) - Pangali Forward P/E|Rega marang bathi mangsa ngarep MetaVia Inc.|NRXS: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Helius Medical (HSDT)|PASG - Rasio prakiraan rega marang bathi|Neuphoria Therapeutics - Prakiraan rega marang bathi|minervaneurosciences.com - Rega marang bathi mangsa ngarep|Athira Pharma - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Addex Therapeutics Ltd. ADXN|ALZN: Pangali Forward P/E|Pangali forward rega marang bathi Cyclerion Therapeutics, Inc. CYCN|PTIX (Protagenic Therapeutics Inc.) - Pangali Forward P/E|Pasithea (KTTA) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Cortigent, Inc. (CRGT)|Rega marang bathi mangsa ngarep ATXI (Avenue Therapeutics Inc.)|Brainstorm Cell Therapeutics, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CARA|CHRO - Rega marang bathi mangsa ngarep|ELYM (Eliem Therapeutics) - Rasio rega marang bathi mangsa ngarep|ITCI: Pangali Forward P/E|Rasio prakiraan rega marang bathi Longboard Pharmaceuticals Inc (LBPH)|Prakiraan rega marang bathi MRNS|Pangali Forward P/E NKGen Biotech Corp|Rega marang bathi mangsa ngarep NeuroBo Pharmaceuticals (NRBO)|SAGE (sagerx.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Synaptogenix SNPX|Trevena Inc. (TRVN) - Rasio prakiraan rega marang bathi|WENA - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Cerevel Corp CERE
